Inventor · disambiguated record
Scott Stirn
Also filed as: STIRN SCOTT
9 granted patents·14 pending applications·57 citations·filing 2009–2024
87Inventor score
Files withARENA PHARM INC11NEUROCRINE BIOSCIENCES INC5BLACKBURN ANTHONY C3JONES ROBERT M2SHAO ZEZHI JESSE1
Top patents by PatentIndex Score
23 records- 0194US8580841B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Nov 12, 2013·21 cites·51 claims
- 0292US9522133B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Granted Dec 20, 2016·9 cites·42 claims
- 0389US2025074874A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2024·Application pending·0 cites
- 0482US9085581B2Processes for the preparation of S1P1 receptor modulators and crystalline forms thereofJONES ROBERT M·Filed 2011·Granted Jul 21, 2015·6 cites·30 claims
- 0582US8980891B2Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoSTIRN SCOTT·Filed 2010·Granted Mar 17, 2015·13 cites·13 claims
- 0681US2023257349A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2022·Application pending·0 cites
- 0777US9365521B2Non-hygroscopic salts of 5-HT2C agonistsBLACKBURN ANTHONY C·Filed 2011·Granted Jun 14, 2016·4 cites·26 claims
- 0875US9248133B2Salts of lorcaserin with optically active acidsBLACKBURN ANTHONY C·Filed 2011·Granted Feb 2, 2016·3 cites·24 claims
- 0972US10226471B2Modified-release dosage forms of 5-HT2C agonists useful for weight managementARENA PHARM INC·Filed 2017·Granted Mar 12, 2019·1 cites·7 claims
- 1072US2020407316A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2020·Application pending·0 cites
- 1167US2019135752A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2018·Application pending·0 cites
- 1266US2022023266A1Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasiaNEUROCRINE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1366US2023233534A1Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1s)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amineNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1462US2017217885A1SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2016·Application pending·0 cites
- 1559US10463676B2Modified-release dosage forms of 5-HT2C agonists useful for weight managementARENA PHARM INC·Filed 2019·Granted Nov 5, 2019·0 cites·15 claims
- 1650US2023065034A1Crf receptor antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1747US2013315994A1Modified-release dosage forms of 5-ht2c agonists useful for weight managementSHAO ZEZHI JESSE·Filed 2011·Application pending·0 cites
- 1847US2023255942A1Crf1 receptor antagonist for the treatment of congenital adrenal hyperplasiaNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1944US12486250B2Muscarinic receptor 4 antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 2, 2025·0 cites·2 claims
- 2043US2017096398A1Non-hygroscopic salts of 5-ht2c agonistsARENA PHARM INC·Filed 2016·Application pending·0 cites
- 2141US2016151381A1Salts of lorcaserin with optically active acidsARENA PHARM INC·Filed 2015·Application pending·0 cites
- 2241US2015284399A1Processes for the preparation of s1p1 receptor modulators and crystalline forms thereofARENA PHARM INC·Filed 2015·Application pending·0 cites
- 2338US2014148442A1Fast-dissolve dosage forms of 5-ht2c agonistsBLACKBURN ANTHONY C·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Stirn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →